cdmo.directory
← Compare landing

Hongene Biotech Corporation vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryHongene Biotech CorporationSinopep-Allsino Biopharmaceutical Co., Ltd.
SummaryHongene is a vertically-integrated CDMO offering end-to-end oligonucleotide and mRNA manufacturing from raw materials to GMP drug product, with nearly 30 years of RNA-focused expertise and tonne-scale production capacity.GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Services
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Oligonucleotide Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Lyophilization (Freeze Drying)
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Oligonucleotide
  • mRNA
  • Oligonucleotide
  • Peptide
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Formulation development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Lyophilized Vials
  • Expression: Cell-Free
  • Max chemical: Commercial (>100 kg / tonne)
  • Drug Substance (DS)
  • Drug Product (DP)
LocationsData not yet provided.Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Hongene Biotech Corporation alternatives · Sinopep-Allsino Biopharmaceutical Co., Ltd. alternatives

Markdown mirror: /compare/hongene/sinopep.md